Formidable Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Formidable Asset Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-200	Closed	-$11K	–	352
2016 Q1	$11K	Hold	200	–	–	0.01%	345
2015 Q4	$12K	Hold	200	–	–	0.01%	360
2015 Q3	$12K	Hold	200	–	–	0.01%	382
2015 Q2	$14K	Hold	200	–	–	0.01%	319
2015 Q1	$14K	Hold	200	–	–	0.01%	314
2014 Q4	$13K	Hold	200	–	–	0.01%	306
2014 Q3	$13K	Hold	200	–	–	0.01%	296
2014 Q2	$12K	Hold	200	–	–	0.01%	329
2014 Q1	$12K	Hold	200	–	–	0.01%	301
2013 Q4	$11K	Hold	200	–	–	0.01%	326
2013 Q3	$10K	Buy	+200	New	+$9.48K	0.01%	305

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $3.51B AUM 13.98% 1-Year Est. Return

LFM

Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Formidable Asset Management's PPH Position: Q2 2016 in Review

Formidable Asset Management sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2016, closing a stake of 200 shares — an estimated $11K sold.

Formidable Asset Management first reported a position in PPH in Q3 2013 and held it in 11 quarters. The position peaked at $14K in Q2 2015. 58 funds tracked by Wall St. Rank hold PPH as of Q2 2016.

Formidable Asset Management reported no remaining VanEck Pharmaceutical ETF position as of Q2 2016 after selling out during the quarter.
Formidable Asset Management sold 200 VanEck Pharmaceutical ETF shares in Q2 2016, an estimated $11K.
Formidable Asset Management first reported a position in VanEck Pharmaceutical ETF in Q3 2013 and held it in 11 quarters.
Formidable Asset Management's VanEck Pharmaceutical ETF position peaked at $14K in Q2 2015.
58 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2016.

Based on Formidable Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.